Skip to content

To Study the Efficacy of Vyoshadi Guggulu and Katutumbhi Taila Nasya in Hypothyroidism

A Randomized Control Trial Of Vyoshadi Guggulu And Katutumbhi Taila Nasya Along with Levothyroxine In Hypothyroidism w.s.r. Thyroid Stimulating Hormone - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073875
Enrollment
70
Registered
2024-09-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

None listed

Sponsors

Pallavi Vasant Valvi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient on TSH value above 5 mIu/L Patient having clinical features of hypothyroidism and fulfilling diagnostic criteria of this study Patients who are willing to participate in trial and ready to give written consent Patients of either sex aged between 18-60 years irrespective of caste religion socioeconomic and educational status Patient with controlled HTN BP Systolic less than 150 and Diastolic less than90 mmHg and DM having FBS more than 130 mg/dl and PMBS more than 200 mg/dl Patients who are fulfilling the criteria of clinical hypothyroidism score more than 5 according to Zulewsks scale Patient fit for Nasya karma

Exclusion criteria

Exclusion criteria: Patients who are suffering from Congenital Hypothyroidism Neoplasia Toxic Goitre Patients who had undergone any type of Thyroid surgery Patients who are not willing to participate in trial and not ready to give written consent Patients having age below 18 years and above 60 years Pregnant women and Lactating mother Patients on prolonged medication more than 6 week with corticosteroids or any drug that may had an influence on the outcome of study Patients who are currently participating in any other clinical trial from last 6 months Patients who has uncontrolled HTN BP Systolic more than 150 Diastolic more than 90 mmHg DM FBS more than 130 mg/dl and PMBS more than 200 mg/dl or any other systemic illness Patient Unfit for Nasya Karma

Design outcomes

Primary

MeasureTime frame
To Evaluate The Efficacy Of Vyoshadi Guggulu and Katutumbhi Taila Nasya Along With Levothyroxine In The Management of Hypo - thyriodism w.s.r Thyriod Stimuting Hormone Levels over 30 days of time span.Timepoint: On 0th day ,15 th day ,30 th day

Secondary

MeasureTime frame
1. To evaluate the efficacy of Vyoshadi Guggulu & Katutumbhi Taila Nasya along with levothyroxine in Hypothyriodism on Zulwesk’s scale. 2. To Study Hypothyroidism & its Ayurvedic perspective over 18 months.Timepoint: On 0 th day 15 th day 30 th day

Countries

India

Contacts

Public ContactJayant Gulhane

Government Ayurveda College And Hospital Nagpur

jayant.gulhane.62.6@gmail.com9822922399

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026